HuagongsheHuagongshe Chemistry Print Report · For research reference only
Ethyl(4-piperidin-4-yl-piperazin-1-yl)-acetate → (R)-2-[4-(4-ethoxycarbonylmethyl-piperazin-1-yl)-piperidin-1-yl]-1-(2-methoxy-7-methyl-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Ethyl(4-piperidin-4-yl-piperazin-1-yl)-acetate | HCID 57848475 | — |
| Reactant | HCID 178493965 | HCID 178493965 | — |
| Product | (R)-2-[4-(4-ethoxycarbonylmethyl-piperazin-1-yl)-piperidin-1-yl]-1-(2-methoxy-7-methyl-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate | HCID 178472621 | — |
Reaction Steps
Prepared analogously to Example 7i from 150 mg (0.27 mmol) (R)-1-carboxy-2-(2-methoxy-7-methyl-1H-benzimidazol-5-yl)-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate and 85 mg (0.33 mmol) ethyl (4-piperidin-4-yl-piperazin-1-yl)-acetate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07625886B2 |
| Source dataset | uspto-grants-2009_12 |
| ORD ID | ord-5ba6a813b2704af1a2b994a1c6c62cbb |
| Source note | uspto-grants-2009_12 |